Search - tctmd.com

Displaying 1 - 20 of 69

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2019

TCTMD News Team

December 30, 2019

News CV Team Pro

The Emory Healthcare Cath Lab Teams

L.A. McKeown

December 18, 2019

News Daily News

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

L.A. McKeown

December 17, 2019

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Daily News

Apple Watch as an ECG? Feasible, May Prove Useful in Emergencies

Yael L. Maxwell

November 28, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Daily News

Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults

Yael L. Maxwell

October 10, 2019

News Conference News TCT 2019

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Todd Neale

October 09, 2019

Presentation TCT 2019

Device-Based Autonomic Modulation in Renal Failure

Presenter: Roland Schmieder

September 28, 2019

Presentation TCT 2019

Device-Based Autonomic Modulation in Supraventricular and Ventricular Arrhythmias

Presenter: Christian Ukena

September 28, 2019

Presentation TCT 2019

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Presenter: Philipp Lurz

September 28, 2019

Presentation TCT 2019

Innovative Trial Designs in Device-Based Hypertension Treatment

Presenter: Konstantinos Tsioufis

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presentation TCT 2019

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presenter: Bernard Gersh

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presentation TCT 2019

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Presenter: Naomi Fisher

September 28, 2019

Presentation TCT 2019

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Presenter: Daniel Burkhoff

September 28, 2019

Presentation TCT 2019

Update on ROX Trial Program (AV Fistula Creation)

Presenter: Melvin Lobo

September 28, 2019

Presentation TCT 2019

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Presenter: Justin Davies

September 28, 2019

Advertisement

Year in Review: Physicians Pick the Biggest News of 2019

The Emory Healthcare Cath Lab Teams

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Apple Watch as an ECG? Feasible, May Prove Useful in Emergencies

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

TCTMD’s Top 10 Most Popular Stories for October 2019

Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Device-Based Autonomic Modulation in Renal Failure

Device-Based Autonomic Modulation in Supraventricular and Ventricular Arrhythmias

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Innovative Trial Designs in Device-Based Hypertension Treatment

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Update on ROX Trial Program (AV Fistula Creation)

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content